Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Feb 12, 2019 10:19am
23 Views
Post# 29352317

RE:6k this morning.

RE:6k this morning.
StuinSea wrote:
https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=12694335&type=HTML&symbol=TRPX&companyName=Therapix+Biosciences+Ltd.&formType=6-K&dateFiled=2019-02-12


Thanks for ll the great info StuinSea
Good things are on the way.  I would still love to know who was buying so many share those couple days.  Somebody was loading up shares expecting somethign good to happen soon.  Companies do not go from trading 20K per day to 600K in two days for no reason.
TRPX has a chance to be first to market with how far along they are with the clinical studies and they are patent protected as well, these guys are work $50million easy.  
Based on the interview posted it sounds like they are going to start trying to publisize this little known company a bit more, but at a $14million market cap this is so cheap, companies pay that jus to get a NASDQ listing.
<< Previous
Bullboard Posts
Next >>